EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C25H29N3O2 |
| Net Charge | 0 |
| Average Mass | 403.526 |
| Monoisotopic Mass | 403.22598 |
| SMILES | CC(=O)Nc1ccc(C2Nc3cc(C)c(C)cc3N=C3CC(C)(C)CC(=O)C32)cc1 |
| InChI | InChI=1S/C25H29N3O2/c1-14-10-19-20(11-15(14)2)28-24(17-6-8-18(9-7-17)26-16(3)29)23-21(27-19)12-25(4,5)13-22(23)30/h6-11,23-24,28H,12-13H2,1-5H3,(H,26,29) |
| InChIKey | WVJPABJAYYPHQO-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| LSM-19351 (CHEBI:107974) is a benzodiazepine (CHEBI:22720) |
| Manual Xrefs | Databases |
|---|---|
| LSM-19351 | LINCS |